Thermo Fisher Scientific offers flexible, scalable, and reliable solutions for laboratories to expand their molecular testing menu beyond SARS‑CoV‑2 with new infectious disease molecular testing panels using their current Applied Biosystems QuantStudio qPCR instrumentation with the same workflow they’ve already mastered. 

Applied Biosystems TrueMark Infectious Disease Research Panels are convenient, duplexed TaqMan assays that are performed on pre-spotted and dried-down plates that include microorganism‑specific pathogens, utilizing real‑time PCR techniques.

This enables rapid, accurate detection and categorization of microorganisms that cause respiratory, vaginal, urinary, gastrointestinal, and sexually transmitted diseases, as well as antibiotic resistance testing.

According to Thermo Fisher Scientific, implementing genetic analysis systems and solutions in the laboratory has been directly linked to improved efficiencies, cost savings, and faster time to reportable results. qPCR can detect slow-growing, difficult-to-cultivate microorganisms, making it ideal for when culture methods are inadequate, ambiguous, time-consuming, difficult, or costly.

TrueMark Infectious Disease Research Solutions are available in customizable options. Customers can choose from an extensive list of pathogens to put on their plate, or 10 different predefined panels in several disease states, with preselected assays targets.

Key features of these molecular testing panels for qPCR include:

Customizable—choose from a selection of 10 predefined panels covering 8 pathogens per panel or customer‑defined panels

Expanded content—panels available for several disease areas

Increased sensitivity—more specific, accurate, and precise than traditional culture and microscopy methods

Timely results—results in as little as 4 hours using real‑time PCR technology

Complete endtoend solution—optimized for use on QuantStudio real‑time PCR systems with verified sample‑to‑answer workflow

For Research Use Only. Not for use in diagnostic procedures.